India’s startup ecosystem must shift its focus from counting patent filings to commercializing intellectual property and building globally competitive, institutionally mature deeptech enterprises to ensure long-term economic sovereignty.
Key Points
- India has recognized over 223,000 startups, but the focus is moving toward converting laboratory research into commercialized, defensible intellectual property assets.
- Deeptech sectors, including semiconductors, biotech, and quantum computing, require patient capital and long-term institutional support rather than rapid, software-style revenue growth.
- The government has introduced the ₹1 trillion Research, Development and Innovation (RDI) Scheme and a ₹10,000 crore Fund of Funds to support long-duration, high-risk technology development.
- Successful commercialization requires a robust bridge between research labs, technology-transfer offices, industrial partners, and domestic certification bodies to reduce reliance on foreign regulatory standards.
- Companies like Nayam, Pandorum, and Peptris exemplify the shift toward IP-led value creation, aiming to solve complex problems in drug discovery and advanced manufacturing.